McKesson Corporation $MCK Shares Sold by Illinois Municipal Retirement Fund

Illinois Municipal Retirement Fund lessened its holdings in shares of McKesson Corporation (NYSE:MCK – Free Report) by 31.6% in the third quarter, Holdings Channel.com reports. The institutional investor owned 5,738 shares of the company’s stock after selling 2,656 shares during the quarter. Illinois Municipal Retirement Fund’s holdings in McKesson were worth $4,899,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Northbridge Financial Group LLC lifted its holdings in shares of McKesson by 2.1% in the 3rd quarter. Northbridge Financial Group LLC now owns 766 shares of the company’s stock worth $706,000 after purchasing an additional 16 shares during the last quarter. AMG National Trust Bank grew its stake in McKesson by 2.0% during the 3rd quarter. AMG National Trust Bank now owns 3,596 shares of the company’s stock worth $3,071,000 after buying an additional 69 shares during the last quarter. Keybank National Association OH grew its stake in McKesson by 4.5% during the 3rd quarter. Keybank National Association OH now owns 4,460 shares of the company’s stock worth $3,808,000 after buying an additional 192 shares during the last quarter. Cornerstone Wealth Management LLC acquired a new stake in McKesson in the third quarter worth $256,000. Finally, Kinsale Capital Group Inc. lifted its stake in McKesson by 16.2% in the third quarter. Kinsale Capital Group Inc. now owns 22,057 shares of the company’s stock valued at $18,833,000 after buying an additional 3,080 shares during the last quarter. Institutional investors and hedge funds own 85.07% of the company’s stock.

McKesson Trading Up 0.0%

MCK stock opened at $1,103.31 on Monday. The firm has a 50-day moving average of $955.45 and a two-hundred day moving average of $874.53. The firm has a market capitalization of $127.39 billion, a PE ratio of 28.37, a P/E/G ratio of 1.86 and a beta of 0.27. McKesson Corporation has a one year low of $723.68 and a one year high of $1,121.50.

McKesson (NYSE:MCK – Get Free Report) last issued its quarterly earnings results on Wednesday, November 4th. The company reported $11.68 earnings per share for the quarter, beating analysts’ consensus estimates of $10.72 by $0.96. The business had revenue of $110.96 billion for the quarter, compared to the consensus estimate of $109.90 billion. McKesson had a negative return on equity of 202.94% and a net margin of 1.12%. McKesson’s revenue for the quarter was up 7.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $9.86 earnings per share. On average, equities research analysts anticipate that McKesson Corporation will post 46.16 earnings per share for the current year.

McKesson Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, January 4th. Shareholders of record on Tuesday, December 1st will be paid a dividend of $0.94 per share. This represents a $3.76 annualized dividend and a yield of 0.3%. The ex-dividend date of this dividend is Tuesday, December 1st. McKesson’s payout ratio is 9.67%.

Insider Activity

In other news, CAO B Jr sold 111 shares of the company’s stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $891.45, for a total value of $98,950.95. Following the transaction, the chief accounting officer owned 521 shares in the company, valued at $464,445.45. This represents a 17.56% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Francisco Fraga sold 800 shares of the stock in a transaction that occurred on Thursday, October 15th. The stock was sold at an average price of $995.80, for a total transaction of $796,640.00. Following the completion of the sale, the executive vice president directly owned 5,423 shares of the company’s stock, valued at $5,400,223.40. This trade represents a 12.86% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 2,161 shares of company stock worth $2,242,515. Company insiders own 0.06% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on MCK shares. Weiss Ratings raised shares of McKesson from a “buy (b)” rating to a “buy (b+)” rating in a report on Monday, November 9th. Citigroup lifted their price objective on shares of McKesson from $945.00 to $1,000.00 and gave the company a “buy” rating in a research report on Friday, July 24th. Barclays boosted their target price on shares of McKesson from $925.00 to $1,000.00 and gave the company an “overweight” rating in a research note on Wednesday, August 19th. Wells Fargo & Company upped their target price on shares of McKesson from $812.00 to $933.00 and gave the stock an “equal weight” rating in a research report on Tuesday, August 11th. Finally, Evercore restated an “outperform” rating and issued a $950.00 price target (down from $1,000.00) on shares of McKesson in a research note on Thursday, August 6th. Fifteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $1,040.29.

Read Our Latest Stock Analysis on McKesson

About McKesson

(Free Report)

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and other medical products. Its customers include pharmacies, hospitals, health systems, clinics and other healthcare providers. The company also provides medical-surgical supplies and technology and services that support pharmacy operations, prescription management and care delivery. Its offerings include specialized support for oncology and other areas of care. Founded in 1833, McKesson serves customers primarily in the United States and Canada.

Read More

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK – Free Report).

Institutional Ownership by Quarter for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.